US: AVEFF - Avecho Biotechnology Limited

半年間の収益性: +500%

プロモーションスケジュール Avecho Biotechnology Limited


会社について

Avecho Biotechnology Limited, a biotechnology company, engages in the development and commercialization of human and animal health related products using its proprietary drug delivery system and Tocopherol Phosphate Mixture in Australia. The company operates through Production and Human Health segments. It also produces and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. In addition, the company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches.

さらに詳しく
Further, it develops feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney for treatment of osteoarthritis. The company was incorporated in 1992 and is based in Clayton, Australia.

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета aud
Сайт https://avecho.com.au
Цена ао 0.0012
1日あたりの価格変動: 0% (0.0012)
週ごとの価格変動: 0% (0.0012)
月ごとの料金変更: 0% (0.0012)
3ヶ月間の価格変動: +500% (0.0002)
半年間の価格変動: +500% (0.0002)
年間の価格変動: -65.71% (0.0035)
3年間の価格推移: -76% (0.005)
5年間の価格推移: 0% (0.0012)
10年間の価格推移: 0% (0.0012)
年初からの価格変動: 0% (0.0012)

過小評価

名前 意味 学年
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
合計: 2.5

効率

名前 意味 学年
ROA, % 0 0
ROE, % 0 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0.0243

義務

名前 意味 学年
Debt/EBITDA 0 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % -88.83 0
収益性 Ebitda, % -366.81 0
収益性 EPS, % 0 0
合計: 0

スーパーバイザー 役職 支払い 生年
Dr. Paul Gavin BSc (Hons), Ph.D. Chief Executive Officer
Dr. Roksan Libinaki Ph.D. Chief Operating Officer
Ms. Melanie Jaye Leydin B.Bus, C.A. Company Secretary & CFO 1973 (52 年)

住所: Australia, Clayton, 2A Westall Road - Googleマップで開く, Yandexマップを開く
Webサイト: https://avecho.com.au